PVI
ALDX icon

Pura Vida Investments’s Aldeyra Therapeutics ALDX Stock Holding History

Pura Vida Investments’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-125,000
Closed -$669K – 79
2016
Q4 		$669K Buy
125,000
+10,933
+10% +$64.1K 0.25% 58
2016
Q3 		$892K Buy
114,067
+36,567
+47% +$223K 0.27% 72
2016
Q2 		$441K Buy
77,500
+20,000
+35% +$112K 0.19% 67
2016
Q1 		$241K Hold
57,500
– – 0.11% 73
2015
Q4 		$390K Hold
57,500
– – 0.16% 68
2015
Q3 		$335K Hold
57,500
– – 0.19% 59
2015
Q2 		$511K Buy
+57,500
New +$496K 0.26% 61

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pura Vida Investments's ALDX Position: Q1 2017 in Review

Pura Vida Investments sold out of Aldeyra Therapeutics (ALDX) in Q1 2017, closing a stake of 125,000 shares — an estimated $669K sold.

Pura Vida Investments first reported a position in ALDX in Q2 2015 and held it in 7 quarters. The position peaked at $892K in Q3 2016. 24 funds tracked by Wall St. Rank hold ALDX as of Q1 2017.

  • Pura Vida Investments reported no remaining Aldeyra Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Pura Vida Investments sold 125,000 Aldeyra Therapeutics shares in Q1 2017, an estimated $669K.
  • Pura Vida Investments first reported a position in Aldeyra Therapeutics in Q2 2015 and held it in 7 quarters.
  • Pura Vida Investments's Aldeyra Therapeutics position peaked at $892K in Q3 2016.
  • 24 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2017.

Based on Pura Vida Investments's 13F filing for Q1 2017, filed 15 May 2017.